This list is an analysis based on recent market events. It's not an investment recommendation.
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
FAQs
What is Waverley Pharma stock price today?▼
The current price of 5GZ.STU is €0.01 EUR — it has increased by +0% in the past 24 hours. Watch Waverley Pharma stock price performance more closely on the chart.
What is Waverley Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Waverley Pharma stocks are traded under the ticker 5GZ.STU.
Is Waverley Pharma stock price growing?▼
5GZ.STU stock has risen by +0% compared to the previous week, the month change is a +33.33% rise, over the last year Waverley Pharma has showed a -14.29% decrease.
What is Waverley Pharma market cap?▼
Today Waverley Pharma has the market capitalization of 324,000
What is Waverley Pharma revenue for the last year?▼
Waverley Pharma revenue for the last year amounts to 844,586.6 EUR.
What is Waverley Pharma net income for the last year?▼
5GZ.STU net income for the last year is -308,565.44 EUR.
In which sector is Waverley Pharma located?▼
Waverley Pharma operates in the Health & Wellness sector.
When did Waverley Pharma complete a stock split?▼
Waverley Pharma has not had any recent stock splits.
Where is Waverley Pharma headquartered?▼
Waverley Pharma is headquartered in Winnipeg, Canada.